Patents Represented by Attorney Jan P. Brouard
  • Patent number: 7619007
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Grant
    Filed: November 22, 2005
    Date of Patent: November 17, 2009
    Assignee: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Laurence R. Meyerson